On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
All content for Sharp China with Bill Bishop is the property of Andrew Sharp and Sinocism’s Bill Bishop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
(Preview) A Basic Consensus on Arrangements to Address US-China Concerns; The New Five-Year Plan Sounds Familiar; Nexperia as an Object Lesson
Sharp China with Bill Bishop
12 minutes 25 seconds
1 week ago
(Preview) A Basic Consensus on Arrangements to Address US-China Concerns; The New Five-Year Plan Sounds Familiar; Nexperia as an Object Lesson
On today's show Andrew and Bill begin with the looming Trump-Xi meeting in Seoul, South Korea, and the "consensuses" agreed upon in Kuala Lampur this past weekend. Topics include: Treasury Scott Bessent's comments indicate that the recent rare earth export controls could be delayed by a year, questions about what the U.S. might have conceded to secure that delay, talk of removing fentanyl tariffs, how Beijing sees the US in 2025, and a Trump visit to Beijing that may portend relative stability in the short term. At the end: Parsing the five-year plan and two stories about the Chinese economy, the scale of Europe's Nexperia problem becomes clearer, and thoughts on the challenge facing Europe and the United States as they attempt to build secure supply chains in the years to come.
Sharp China with Bill Bishop
On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
